Evolution of the Average Target: Experian plc

Evolution of the Target Price: Experian plc

Changes in Analyst Recommendations: Experian plc

5531753afda6992885a270b0993.utzMgf-CsCAN45tgJ51JPJjZRU8TW-MscCwjq_q1_ZA.zqui3onHxHVVifIjRPZxbNy7FHwlF4ZNO25GybODudaDv6nuqrb2Qn-Pow~c7c3c06613ed718368306ae63675d34f
07-30 Morningstar Downgrades Experian to Hold Rating MT
07-20 BofA Restarts Experian Coverage at Buy, Sees 'Low' Downside Risk From AI MT
07-16 Experian: Underlying growth remains resilient, H2 recovery in sight Alphavalue
07-13 Morgan Stanley Research: Experian to Log 7% Organic Revenue Growth in Fiscal Q1 MT
06-10 Deutsche Bank Cuts Experian PT, Affirms Buy Rating MT
06-10 Deutsche Bank Research raises easyJet to 'hold' AN
05-26 Stifel Reduces Experian's PT, Affirms Buy Rating MT
05-26 Stifel Lowers Target on Experian, Shares Stagnate Zonebourse
05-26 Barclays ups British Land; BofA cuts Vodafone AN
05-22 UBS Maintains Buy Rating and Raises Price Target for Experian Zonebourse
05-21 Deutsche, Goldman cut Experian price targets AN
05-21 Experian Kept at Buy as BofA Notes In-line FY26 Results, AI Concerns; Estimates Updated MT
05-19 AlphaValue/Baader Europe Upgrades Experian to Add, Lifts PT MT
04-22 AlphaValue/Baader Europe Downgrades Experian to Reduce, Trims PT MT
04-02 RBC raises Berkeley; Berenberg raises BHP AN
02-09 Deutsche cuts Unilever; Jefferies cuts Greggs AN
02-09 AlphaValue/Baader Europe Downgrades Experian on AI-driven Price, Competitive Pressures MT
02-06 Experian: Valuation reset amid AI uncertainity Alphavalue
01-22 BofA Trims Experian EPS Forecasts on Expected 'Marginally Lower' FY26 Organic Revenue Growth; Buy Rating Kept MT
01-21 Experian reaffirms FY guidance after steady Q3 Alphavalue
12-11 Experian on JPMorgan focus list at 'overweight' AN
12-08 JPMorgan cuts M&G, UBS cuts Trainline AN
11-21 Citi Upgrades Experian to Buy, Trims PT MT
11-21 Citi lifts Experian; Goldman Sachs cuts Ithaca AN
11-12 Tandem Diabetes Care, Inc. Appoints Sandra Beaver to Board of Directors, Effective November 7, 2025 CI

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+26.03%
+9.69%
+30.43%
Average +22.05%
Weighted average by Cap. +23.18%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
39.84USD
Average target price
50.21USD
Spread / Average Target
+26.03%
High Price Target
63.20USD
Spread / Highest target
+58.63%
Low Price Target
33.39USD
Spread / Lowest Target
-16.18%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. EXPN Stock
  4. Consensus Experian plc